Page 3 - Nasdaq Amph News Today

Russell Investments Group Ltd. grew its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 1.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,704 shares of the company’s stock after purchasing an additional 488 shares during the period. Russell Investments […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 2,890,000 shares, an increase of 15.6% from the October 31st total of 2,500,000 shares. Currently, 8.1% of the shares of the stock are sold short. Based […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) saw a significant decrease in short interest in October. As of October 31st, there was short interest totalling 2,500,000 shares, a decrease of 6.0% from the October 15th total of 2,660,000 shares. Currently, 6.9% of the company’s shares are sold short. Based on an average daily trading […]

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) will be announcing its earnings results on Wednesday, November 8th. Persons that are interested in participating in the company’s earnings conference call can do so using this link. Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) last released its quarterly earnings data on Tuesday, August 8th. The company reported […]

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) is scheduled to be issuing its quarterly earnings data on Wednesday, November 8th. Parties interested in listening to the company’s conference call can do so using this link. Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) last issued its quarterly earnings results on Tuesday, August 8th. The company reported […]

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a research note issued to investors on Thursday morning. A number of other equities research analysts have also weighed in on AMPH. Piper Sandler raised their price objective on Amphastar Pharmaceuticals from $66.00 to $71.00 in […]

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a report published on Thursday. A number of other equities analysts have also recently commented on the company. Piper Sandler raised their target price on Amphastar Pharmaceuticals from $66.00 to $71.00 in a report on Wednesday, […]

Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price target boosted by Piper Sandler from $55.00 to $66.00 in a report published on Tuesday, FlyOnTheWall reports. Separately, StockNews.com raised Amphastar Pharmaceuticals from a buy rating to a strong-buy rating in a report on Wednesday, June 21st. Amphastar Pharmaceuticals Price Performance AMPH stock opened at $61.62 […]

Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) reached a new 52-week high on Tuesday after Piper Sandler raised their price target on the stock from $55.00 to $66.00. The stock traded as high as $59.98 and last traded at $59.56, with a volume of 116364 shares changing hands. The stock had previously […]

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday. Separately, Piper Sandler boosted their price target on Amphastar Pharmaceuticals from $43.00 to $55.00 in a research note on Thursday, June 15th. Amphastar Pharmaceuticals Stock Down 2.1 % […]